Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania

被引:19
作者
Paulozzi, Leonard J. [1 ]
Stier, Daniel D. [2 ]
机构
[1] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA
[2] William Mitchell Coll Law, Publ Hlth Law Network, St Paul, MN USA
关键词
opioid; overdose; regulation; drug abuse; poisoning; mortality; UNITED-STATES;
D O I
10.1057/jphp.2010.27
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Drug overdose mortality nearly doubled in the United States from 1999 to 2004, with most of the increase due to prescription drug overdoses. Studying mortality rates in states that did not experience such increases may identify successful prescription overdose prevention strategies. We compared New York, a state that did not experience an overdose increase, with its neighbor, Pennsylvania. New York and Pennsylvania had prescription drug monitoring programs (PDMPs), but New York's PDMP was better funded and made use of serialized, tamperproof prescription forms. Per capita usage of the major prescription opioids in New York was two-thirds that of Pennsylvania. The drug overdose death rate in Pennsylvania was 1.6 times that of New York in 2006. Differences between New York and Pennsylvania might be due to the regulatory environment in New York State. Journal of Public Health Policy (2010) 31, 422-432. doi:10.1057/jphp.2010.27
引用
收藏
页码:422 / 432
页数:11
相关论文
共 50 条
  • [31] Preventing Prescription Drug Diversion
    Dumonchelle, Janet V.
    JOURNAL OF ADDICTIONS NURSING, 2015, 26 (03) : 109 - 110
  • [32] Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
    Pardo, Bryce
    ADDICTION, 2017, 112 (10) : 1773 - 1783
  • [33] Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City
    Bachhuber, Marcus A.
    Tuazon, Ellenie
    Nolan, Michelle L.
    Kunins, Hillary V.
    Paone, Denise
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (05) : 734 - 739
  • [34] The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020
    Adalbert, Jenna R.
    Syal, Amit
    Varshney, Karan
    George, Brandon
    Hom, Jeffrey
    Ilyas, Asif M.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [35] Prescription Drug Monitoring and Dispensing of Prescription Opioids
    Brady, Joanne E.
    Wunsch, Hannah
    DiMaggio, Charles
    Lang, Barbara H.
    Giglio, James
    Li, Guohua
    PUBLIC HEALTH REPORTS, 2014, 129 (02) : 139 - 147
  • [36] Suicidal Drug Overdoses in New Mexico: A 5-year Retrospective Review
    Szymanski, Linda J.
    Aurelius, Michelle B.
    Szymanski, Sarah A.
    Lathrop, Sarah L.
    JOURNAL OF FORENSIC SCIENCES, 2016, 61 (03) : 661 - 665
  • [37] Explaining Spatial Disparities in Fatal Drug Overdoses, 1970-2016
    Davlasheridze, Merl
    Goetz, Stephan J.
    REVIEW OF REGIONAL STUDIES, 2021, 51 (03) : 292 - 316
  • [38] Racial susceptibility for QT prolongation in acute drug overdoses
    Manini, Alex F.
    Stimmel, Barry
    Vlahov, David
    JOURNAL OF ELECTROCARDIOLOGY, 2014, 47 (02) : 244 - 250
  • [39] Prescription drug misuse: quantifying the experiences of New Zealand GPs
    Sheridan, Janie
    Jones, Sophie
    Aspden, Trudi
    JOURNAL OF PRIMARY HEALTH CARE, 2012, 4 (02) : 106 - 112
  • [40] Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
    Martins, Silvia S.
    Ponicki, William
    Smith, Nathan
    Rivera-Aguirre, Ariadne
    Davis, Corey S.
    Fink, David S.
    Castillo-Carniglia, Alvaro
    Henry, Stephen G.
    Marshall, Brandon D. L.
    Gruenewald, Paul
    Cerda, Magdalena
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 74 : 174 - 180